Inpixon Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Cash Flows Used in Operating Activities
Net (loss) income	$ (20,330)	$ (11,557)	$ 14,506	$ (12,539)	$ (31,887)	$ 1,967
Adjustment to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization					650	625
Amortization of intangible assets					3,026	2,007
Amortization of right of use asset					353	370
Stock based compensation	700		2,100		2,274	7,149
Earnout expense valuation benefit					(2,827)	0
Loss on exchange of debt for equity	0		0		0	30
Amortization of debt discount					0	224
Amortization of original issued discount					(92)	0
Accrued interest income, related party					0	(1,627)
Unrealized gain on note					344	(490)
Recovery for valuation allowance for held for sale loan	0		(7,462)		0	(7,345)
Gain on settlement of related party promissory note and loan related party receivable	0		(49,817)		0	(49,817)
Deferred income tax					(1)	(4,507)
Unrealized gain/(loss) on equity securities	(247)		28,965		1,256	28,965
Impairment of goodwill	7,570		0		7,570	0
Other					181	57
Changes in operating assets and liabilities:
Accounts receivable and other receivables					361	532
Inventory					285	(555)
Prepaid expenses and other current assets					1,357	(319)
Other assets					25	203
Accounts payable					(1,498)	(331)
Accrued liabilities					542	2,494
Income tax liabilities					(40)	6,711
Deferred revenue					(1,096)	(238)
Operating lease obligation					(327)	(364)
Other liabilities					0	96
Net Cash Used in Operating Activities					(19,544)	(14,163)
Cash Flows Used in Investing Activities
Purchase of property and equipment					(140)	(149)
Investment in capitalized software					(306)	(373)
Investments in short term investments					0	(2,000)
Purchase of convertible note					(5,500)	0
Purchases of treasury bills					0	(63,362)
Sales of treasury bills					43,001	28,000
Purchase of Systat licensing agreement					0	(900)
Acquisition of Game Your Game					0	184
Acquisition of CXApp					0	(15,186)
Acquisition of Visualix					0	(61)
Net Cash Provided By (Used in) Investing Activities					37,055	(53,847)
Cash From Financing Activities
Net proceeds from issuance of preferred stock and warrants					46,906	0
Net proceeds from issuance of common stock and warrants					0	77,853
Net proceeds from promissory note					364	0
Cash paid for redemption of preferred stock series 7					(49,250)	0
Taxes paid related to net share settlement of restricted stock units					(336)	(1,687)
Loans to related party					0	(117)
Repayment of CXApp acquisition liability					(1,847)	(137)
Repayment of acquisition liability to Nanotron shareholders					0	(467)
Repayment of acquisition liability to Locality shareholders					0	(500)
Net Cash (Used In) Provided By Financing Activities					(4,163)	74,945
Effect of Foreign Exchange Rate on Changes on Cash					(73)	(19)
Net Increase in Cash and Cash Equivalents					13,275	6,916
Cash and Cash Equivalents - Beginning of period		$ 52,480		$ 17,996	52,480	17,996	$ 17,996
Cash and Cash Equivalents - End of period	$ 65,755		$ 24,912		65,755	24,912	$ 52,480
Cash paid for:
Interest					2	1
Income Taxes					100	0
Non-cash investing and financing activities
Common shares issued for extinguishment of debt					2,000	1,500
Common shares issued for CXApp Earnout Payment					3,697	0
Common shares issued in exchange for warrants					14	0
Right of use asset obtained in exchange for lease liability					284	0
Settlement of Sysorex Note					0	7,462
Investment in equity securities					0	58,905
Common shares issued for CXApp acquisition					0	10,000
Common shares issued for Game Your Game acquisition					0	1,403
Common shares issued for Visualix asset acquisition					$ 0	$ 429